Efficacy measures included as follows : mean change in nocturia at 3-month intervals up to 48 months ; proportion of patients with improvement/worsening in nocturia ; nocturnal voiding frequency at baseline and study end , overall and by baseline subgroups ; and nocturnal voiding frequency < 2 at study end in patients with a baseline score 2 .